Long-term health outcomes of children born to mothers with hyperemesis gravidarum: a systematic review and meta-analysis
- PMID: 35367190
- DOI: 10.1016/j.ajog.2022.03.052
Long-term health outcomes of children born to mothers with hyperemesis gravidarum: a systematic review and meta-analysis
Abstract
Objective: Hyperemesis gravidarum is characterized by severe nausea and vomiting in pregnancy, frequently resulting in severe maternal nutritional deficiency. Maternal undernutrition is associated with adverse offspring health outcomes. Whether hyperemesis gravidarum permanently affects offspring health remains unclear. This review aimed to evaluate the effects of maternal hyperemesis gravidarum on offspring health.
Data sources: MEDLINE and Embase were searched from inception to September 6, 2021.
Study eligibility criteria: Studies reporting on health at any age beyond the perinatal period of children born to mothers with hyperemesis gravidarum were included.
Methods: Two reviewers independently selected studies and extracted data. The Newcastle-Ottawa Quality Assessment Scale was used to assess risk of bias. We conducted a narrative synthesis and meta-analysis where possible. In meta-analyses with high heterogeneity (I2>75%), we did not provide a pooled odds ratio.
Results: Nineteen studies were included in this systematic review (n=1,814,785 offspring). Meta-analysis (n=619, 2 studies: 1 among adolescents and 1 among adults) showed that hyperemesis gravidarum was associated with anxiety disorder (odds ratio, 1.74; 95% confidence interval, 1.04-2.91; I2, 0%) and sleep problems in offspring (odds ratio, 2.94; 95% confidence interval, 1.25-6.93; I2, 0%). Hyperemesis gravidarum was associated with testicular cancer in male offspring aged up to 40 years on meta-analysis (5 studies, n=20,930 offspring), although heterogeneity was observed on the basis of a wide 95% prediction interval (odds ratio, 1.60; 95% confidence interval, 1.07-2.39; I2, 0%; 95% prediction interval, 0.83-3.08). All 6 studies reporting on attention deficit (hyperactivity) disorder and autism spectrum disorder reported an increase among children of mothers with hyperemesis gravidarum in comparison with children of unaffected mothers. Meta-analysis showed high heterogeneity, precluding us from reporting a pooled odds ratio. Most studies reporting on cognitive and motor problems found an increase among hyperemesis gravidarum-exposed children. One study investigated brain structure and found smaller cortical volumes and areas among children from hyperemesis gravidarum-affected pregnancies than among those from unaffected pregnancies. Studies evaluating anthropometry and cardiometabolic disease risk of hyperemesis gravidarum-exposed children had inconsistent findings.
Conclusion: Our systematic review showed that maternal hyperemesis gravidarum is associated with small increases in adverse health outcomes among children, including neurodevelopmental disorders, mental health disorders, and possibly testicular cancer, although evidence is based on few studies of low quality.
Keywords: autism spectrum disorder; cardiometabolic risk factors; dyssomnias; hyperemesis gravidarum; long-term effects; meta-analysis; neurodevelopmental disorders; systematic review; testicular neoplasms.
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
Similar articles
-
Perinatal outcomes of infants born to mothers with hyperemesis gravidarum: A systematic review and meta-analysis.Eur J Obstet Gynecol Reprod Biol. 2023 May;284:30-51. doi: 10.1016/j.ejogrb.2023.03.004. Epub 2023 Mar 11. Eur J Obstet Gynecol Reprod Biol. 2023. PMID: 36924660
-
Interventions for treating hyperemesis gravidarum: a Cochrane systematic review and meta-analysis.J Matern Fetal Neonatal Med. 2018 Sep;31(18):2492-2505. doi: 10.1080/14767058.2017.1342805. Epub 2017 Jul 11. J Matern Fetal Neonatal Med. 2018. PMID: 28614956
-
Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes.Am J Obstet Gynecol MFM. 2022 Sep;4(5):100682. doi: 10.1016/j.ajogmf.2022.100682. Epub 2022 Jun 18. Am J Obstet Gynecol MFM. 2022. PMID: 35728780
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
-
School performance in offspring born to mothers with hyperemesis gravidarum.Am J Obstet Gynecol. 2025 Sep;233(3):205.e1-205.e12. doi: 10.1016/j.ajog.2025.02.041. Epub 2025 Feb 28. Am J Obstet Gynecol. 2025. PMID: 40024595
Cited by
-
Rates of maternal weight gain over the course of pregnancy and offspring risk of neurodevelopmental disorders.BMC Med. 2023 Mar 23;21(1):108. doi: 10.1186/s12916-023-02799-6. BMC Med. 2023. PMID: 36959571 Free PMC article.
-
Reorganising and improving quality of care for hyperemesis gravidarum in a Danish hospital: a quality improvement project.BMJ Open Qual. 2023 Jul;12(3):e002035. doi: 10.1136/bmjoq-2022-002035. BMJ Open Qual. 2023. PMID: 37463782 Free PMC article.
-
The IRIS clinic: A Protocol for a mixed-methods study evaluating the management of Hyperemesis Gravidarum.Contemp Clin Trials Commun. 2023 Nov 9;39:101227. doi: 10.1016/j.conctc.2023.101227. eCollection 2024 Jun. Contemp Clin Trials Commun. 2023. PMID: 39007106 Free PMC article.
-
Hyperemesis gravidarum and the risk of offspring morbidity: a longitudinal cohort study.Eur J Pediatr. 2024 Sep;183(9):3843-3851. doi: 10.1007/s00431-024-05647-8. Epub 2024 Jun 17. Eur J Pediatr. 2024. PMID: 38884821
-
Diagnosis and treatment of hyperemesis gravidarum.CMAJ. 2024 Apr 14;196(14):E477-E485. doi: 10.1503/cmaj.221502. CMAJ. 2024. PMID: 38621783 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical